These outcomes, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the thought of focusing on ACKR3 as a unique technique to modulate the opioid method, which could open up new therapeutic avenues for opioid-connected Conditions.Importantly, these receptors were being l